Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Asston Pharmaceuticals has informed the BSE that its trading window for dealing in securities will remain closed from 31st January 2026 until 31st March 2026. The closure is in line with the company's insider trading code and SEBI's Prohibition of Insider Trading Regulations. The window is being closed because the company is holding a board meeting to consider raising of funds. During this period, all directors, KMPs, designated persons, connected persons, insiders, and their immediate relatives are prohibited from trading in the company's shares.
This is a routine insider trading compliance announcement, but the mention of a board meeting for 'raising of funds' hints at a possible fundraising activity (such as a preferential issue, rights issue, or QIP) being considered. Shareholders should watch for the outcome of the board meeting, which could lead to dilution. Insiders are restricted from trading until 31st March 2026.